FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. Eksa Mills S.A. de C.V.

    FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.

    High risk
  2. Legacy Pharmaceutical Packaging LLC

    Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.

    High risk
  3. Sterling Pharmaceutical Services, LLC

    Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.

    High risk
  4. Bespoke Apothecary LLC

    Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.

    Low
  5. System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh

    German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.

    High risk
  6. Zhejiang Tianyu Pharmaceutical Co., Ltd.

    Zhejiang Tianyu Pharmaceutical made active pharmaceutical ingredients (API) with current good manufacturing practice (CGMP) deviations in impurity investigations and equipment cleaning.

    High risk
  7. Sanitizer Supply LLC

    FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.

    High risk
  8. Virgin Scent Inc. dba Artnaturals

    FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.

    High risk
  9. Vita Pharmacy, LLC dba Talon Pharmacy of Boerne

    FDA warned Talon Pharmacy of Boerne that it made sterile compounded drugs under insanitary conditions that could contaminate them.

    High risk
  10. Episciences Inc.

    FDA warns Episciences Inc. that its Boise, Idaho plant made OTC drugs without adequate batch testing, process validation and failure investigations.

    High risk
  11. Green Wave Analytical, LLC

    FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.

    High risk
  12. Gordon Laboratories Inc.

    FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.

    High risk
  13. Tramadol US

    FDA warned Tramadol US for selling unapproved, misbranded opioid and benzodiazepine drugs, including tramadol, oxymorphone, and alprazolam, over the internet.

    High risk
  14. Cangene BioPharma, LLC dba Emergent BioSolutions

    FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.

    High risk
  15. Verde Cosmetic Labs LLC

    FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.

    High risk
  16. JB Exchange Inc./Justified Laboratories

    JB Exchange/Justified Laboratories sold unapproved skin tag and mole removal serums online, FDA says.

    High risk
  17. Ariella Naturals

    FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.

    High risk
  18. Amazon.com, Inc.

    Amazon distributes unapproved new drugs for mole and skin tag removal, FDA says.

    High risk
  19. FluxxLab LLC

    FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.

    High risk
  20. DSP Skin Care LLC

    FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.

    High risk
  21. Jose Miguel Gutierrez Salas

    FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.

    High risk
  22. Guangzhou Orchard Aromatherapy & Skin Care Co., Ltd.

    Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.

    High risk
  23. Jost Chemical Co.

    Jost Chemical Co. made active drug ingredients under CGMP deviations, including mold contamination and inadequate investigations.

    High risk
  24. Daniel Fred Goodman, M.D./Goodman Eye Center

    FDA warns Dr. Daniel Fred Goodman/Goodman Eye Center over clinical drug study without required FDA application and missing consent/assent.

    High risk
  25. Custom Research Labs Inc.

    FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.

    High risk
  26. Bi-Coastal Pharma International

    FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.

    High risk
  27. Bioiberica, SAU

    FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.

    High risk
  28. Imprimis Rx LLC

    FDA warns Imprimis Rx over false, misleading promotion of compounded eye drug Pred-Moxi-Brom.

    Low
  29. Genlabs Corporation

    FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.

    High risk
  30. Elite Supplement Center LLC and Elite Training Facility LLC

    FDA warned Elite Supplement Center that it sells five SARM products as unapproved new drugs for human use.

    High risk
  31. DDI Multinacional S.A. de C.V.

    DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.

    High risk
  32. Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.

    Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.

    High risk
  33. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  34. Klarity Kratom

    Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.

    High risk
  35. Kratom Exchange

    FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.

    High risk
  36. Omni Consumer Products LLC d/b/a YoKratom

    FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.

    High risk
  37. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  38. Mirfeel Korea Co., Ltd.

    Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.

    High risk
  39. Industrias Cklass S. de R.L. de C.V.

    FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.

    High risk
  40. Fagron Group B.V.

    FDA warns Fagron over cleaning and cross-contamination failures in active pharmaceutical ingredient repackaging.

    High risk
  41. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  42. Glicerinas Industriales, S.A. de C.V.

    Glicerinas Industriales refused a pre-announced FDA inspection; FDA calls its glycerin drugs adulterated and placed firm on Import Alert 66-79.

    High risk
  43. Hybrid Pharma, LLC

    FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.

    High risk
  44. Smitha C. Reddy, M.D./ACRC Studies, LLC

    FDA warns Dr. Smitha Reddy over clinical trial protocol violations, including wrong drug given and broken blinding.

    High risk
  45. Aire-Master of America, Inc.

    FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.

    High risk
  46. Grimann S.A. de C.V.

    FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.

    Low
  47. New Vitalis, LLC dba New Vitalis Pharmacy

    New Vitalis Pharmacy made sterile compounded drugs under insanitary conditions that risked contamination.

    High risk
  48. Ayuryoga, Inc.

    FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.

    High risk
  49. Santhigram Kerala Ayurvedic Co. of U.S., Inc.

    FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.

    High risk
  50. Colorful Products Corporation

    FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.

    High risk